Male Fertility Opportunity NOA Guide launch signals a direct sales hook with male infertility clinics. Position NOA Guide as a companion diagnostic to support clinical decision-making and expand the NOA treatment pathway. Target fertility centers, urology clinics, and specialty labs with bundled tests (NOA Guide and related SpermQT panels) to drive cross-sell opportunities.

Clinic Partnerships Existing Path Fertility division and Lifeview collaboration indicate a proven channel for commercial distribution. Pursue OEM or white-label arrangements with fertility clinics and diagnostic networks; co-market at conferences; integrate NOA Guide into LIS/LIMS workflows; leverage co-development agreements to broaden test menus.

Epigenetic Upsell The platform's capability to detect dysregulation across multiple genes and pathways supports expansion into autoimmune conditions and autism. Propose multi-disease panels for clinics and research partners; offer tiered pricing for expanded use, analytics services, and data-sharing opportunities.

Funding Growth NIH grant funding demonstrates validated science and potential for co-funded studies. Use grant-backed data to de-risk buyers and to fund pilot programs with key clinics; highlight revenue runway and budget to scale sales and regulatory work.

Thought Leadership Active conference presence and clinician-research leadership create fertile ground for lead generation. Target attendees from fertility, reproductive medicine, and related specialties; convert talks and posters into pilot tests and sales inquiries.